G
Giuseppe Malizia
Researcher at St James's University Hospital
Publications - 39
Citations - 1782
Giuseppe Malizia is an academic researcher from St James's University Hospital. The author has contributed to research in topics: Cirrhosis & Portal hypertension. The author has an hindex of 15, co-authored 36 publications receiving 1341 citations. Previous affiliations of Giuseppe Malizia include University of Palermo.
Papers
More filters
Journal ArticleDOI
Competing risks and prognostic stages of cirrhosis: A 25-year inception cohort study of 494 patients
Gennaro D'Amico,Linda Pasta,Alberto Morabito,Mario D'Amico,M. Caltagirone,Giuseppe Malizia,Fabio Tinè,Gandolfo Giannuoli,M. Traina,G. Vizzini,F. Politi,Andrea De Luca,Roberto Virdone,Anna Licata,Luigi Pagliaro +14 more
TL;DR: Morphological, haemodynamic and clinical stages of cirrhosis have been proposed, although no definite staging system is yet accepted for clinical practice.
Journal ArticleDOI
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents.
Vincenza Calvaruso,Giuseppe Cabibbo,Irene Cacciola,Salvatore Petta,Salvatore Madonia,Alessandro Bellia,Fabio Tinè,Marco Distefano,Anna Licata,Lydia Giannitrapani,Tullio Prestileo,Giovanni Mazzola,Maria Antonietta Di Rosolini,L. Larocca,Gaetano Bertino,A. Digiacomo,F. Benanti,Luigi Guarneri,A. Averna,Carmelo Iacobello,Antonio Magro,I. Scalisi,F. Cartabellotta,Francesca Savalli,Marco Barbara,Antonio Davì,Maurizio Russello,G. Scifo,Giovanni Squadrito,Calogero Cammà,Giovanni Raimondo,Antonio Craxì,Vito Di Marco,A. Craxì,V. Di Marco,C. Cammà,V. Calvaruso,Salvatore Petta,G. Cabbibbo,P. Colletti,G. Mazzola,Antonio Cascio,Giuseppe Montalto,A. Licata,L. Giannitrapani,T. Prestileo,F. Di Lorenzo,Adriana Sanfilippo,A. Ficalora,S. Madonia,F. Tinè,Giuseppe Malizia,Federica Latteri,Marcello Maida,F. Cartabellotta,R. Vassallo,I. Cacciola,Giuseppa Caccamo,S. Maimone,Carlo Saitta,G. Squadrito,G. Raimondo,Luigi Mondello,A. Smedile,S. D’Andrea,G. Bertino,A.L. Ardiri,E. Frazzetto,G. Rigano,Arturo Montineri,L.N. Larocca,Bruno Cacopardo,F. Benanti,M. Russello,R. Benigno,A. Bellia,C. Iacobello,A. Davì,M.A. Di Rosolini,A. Digiacomo,G. Fuduli,G. Scifo,M. Distefano,V. Portelli,F. Savalli,I. Scalici,G. Gioia,A. Magro,Giuseppe Alaimo,M.R. Alinovi,A. Salvo,A. Averna,F. Lomonaco,L. Guarneri,F. Maffeo,E. Falzone,F. Pulvirenti +96 more
TL;DR: In an analysis of data from a large prospective study of patients with hepatitis C virus-associated compensated or decompensated cirrhosis, it is found that the SVR to DAA treatment decreased the incidence of HCC over a mean follow-up of 14 months.
Journal ArticleDOI
Clinical states of cirrhosis and competing risks
Gennaro D'Amico,Alberto Morabito,Mario D'Amico,Linda Pasta,Giuseppe Malizia,Paola Rebora,Maria Grazia Valsecchi +6 more
TL;DR: The aim of this review is to summarise relevant clinical states and to show examples of competing risks analysis in multistate models of cirrhosis.
Journal ArticleDOI
Expression of leukocyte adhesion molecules by mucosal mononuclear phagocytes in inflammatory bowel disease.
Giuseppe Malizia,A Calabrese,Mario Cottone,Massimo Raimondo,Ludwik K. Trejdosiewicz,Chris J. Smart,L. Oliva,Luigi Pagliaro +7 more
TL;DR: The increased expression of intercellular adhesion molecule 1 in inflammatory bowel disease indicates a state of immunological activation induced by local release of inflammatory cytokines.
Journal ArticleDOI
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients.
Giuseppe Cabibbo,Ciro Celsa,Vincenza Calvaruso,Salvatore Petta,Irene Cacciola,M.R. Cannavò,Salvatore Madonia,Margherita Rossi,Bianca Magro,Francesca Rini,Marco Distefano,L. Larocca,Tullio Prestileo,Giuseppe Malizia,Gaetano Bertino,F. Benanti,Anna Licata,I. Scalisi,Giovanni Mazzola,Maria Antonietta Di Rosolini,Giuseppe Alaimo,A. Averna,F. Cartabellotta,N. Alessi,Salvatore Guastella,Maurizio Russello,G. Scifo,Giovanni Squadrito,Giovanni Raimondo,Franco Trevisani,Antonio Craxì,Vito Di Marco,Calogero Cammà,Rete Sicilia Selezione Terapia – Hcv +33 more
TL;DR: In patients with HCV-related cirrhosis who had been successfully treated for early HCC, DAAs significantly improved OS compared with No DAA treatment, and sustained virologic response was a significant predictor of OS.